A class action against Johnson & Johnson over allegedly carcinogenic talcum powder still can't say whether it has sued the correct entities and wants the company to sift through 100 years of corporate history to save it from playing "whack-a-mole".
A class action against REST Super over allegedly inutile income protection premiums has opposed a bid for 'soft' class closure, arguing that registration numbers will provide very little information about the group at this stage.
Amazon US has denied that it has accessorial liability in an Australian Competition and Consumer Commission's suit over alleged unfair contract terms in Prime Video subscription contracts used to introduce advertising to its streaming service.
Select Footy Card has revised its case against memorabilia maker Sport Entertainment Products, maintaining a misuse of market power claim but scrapping its allegation SEP's deal with a rival breached competition law.
A judge has approved a bid to drop claims on behalf of 340 property owners in a class action against Sydney developer Mulpha over a 683-lot development in Glenmore Park.
A judge has refused to make an injunction sought by ASIC against Ryzon Materials, finding the regulator is not entitled to constrain a "hypothetical" transaction while it awaits judgment in its case over the company's battery plant representations.
Property developer Casey Group is weighing a cross-claim against Rossdale Golf Club in response to proceedings launched by Interpac unit Brencorp, which alleges Casey devised an "underhand deal" to block its acquisition of the southeast Melbourne club.
A settlement has been reached in a class action brought on behalf of 120 Liberal candidates who were ineligible for election after the party missed the nomination deadline.
3M has told a judge that a key issue in the Commonwealth’s $2 billion case over PFAS contamination be whether class action settlements can mitigate its limitations defence to a misleading and deceptive conduct claim.
Trial in a shareholder class action against water treatment firm Phoslock and auditor KPMG could be held as late as February 2028 after the plaintiffs flagged plans to tweak their case.